As several countries get ready to reopen their borders for vaccinated foreign travellers, Indians who have received Bharat Biotech’s COVID-19 vaccine Covaxin may not qualify for travelling abroad, as many countries are yet to approve the vaccine.
Multiple reports said that over 130 countries across the globe currently accept Serum Institute of India’s (SII) Covishield vaccine to enter their country, while Covaxin is accepted in only nine nations.
Also, Covaxin is not yet on the World Health Organisation’s (WHO) Emergency Use Listing (EUL).
The latest WHO guidance document shows that Bharat Biotech has submitted its Expression of Interest (EoI) but “more information is required”.
Bharat Biotech was yet to react to the reports.
However, a peer-review publication Clinical Infectious Diseases has noted that Covaxin demonstrates protection against the new COVID-19 variants.
The…
